About
Pangolin Therapeutics develops novel therapeutic agents called Pangomers to target toxic intrinsically disordered proteins involved in diseases such as Type 2 Diabetes, neurodegeneration, and cancers by halting disease progression.
Explore Pangolin Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.